598 related articles for article (PubMed ID: 20531380)
1. Metronomic chemotherapy: new rationale for new directions.
Pasquier E; Kavallaris M; André N
Nat Rev Clin Oncol; 2010 Aug; 7(8):455-65. PubMed ID: 20531380
[TBL] [Abstract][Full Text] [Related]
2. Metronomic chemotherapy: Back to the future!
André N; Padovani L; Verschuur A
Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
[TBL] [Abstract][Full Text] [Related]
3. [Metronomic chemotherapy in 2011: update and perspectives].
Benbrahim Z; Massard C; El Mesbahi O
Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
[TBL] [Abstract][Full Text] [Related]
4. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
5. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
[TBL] [Abstract][Full Text] [Related]
6. Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?
Norrby K
APMIS; 2014 Jul; 122(7):565-79. PubMed ID: 24164171
[TBL] [Abstract][Full Text] [Related]
7. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
8. Metronomics: towards personalized chemotherapy?
André N; Carré M; Pasquier E
Nat Rev Clin Oncol; 2014 Jul; 11(7):413-31. PubMed ID: 24913374
[TBL] [Abstract][Full Text] [Related]
9. Metronomic chemotherapy and immunotherapy in cancer treatment.
Chen YL; Chang MC; Cheng WF
Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
[TBL] [Abstract][Full Text] [Related]
10. Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package.
Bahl A; Bakhshi S
Indian J Pediatr; 2012 Dec; 79(12):1617-22. PubMed ID: 22544675
[TBL] [Abstract][Full Text] [Related]
11. Metronomic dosing of chemotherapy: applications in pediatric oncology.
Stempak D; Seely D; Baruchel S
Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
[TBL] [Abstract][Full Text] [Related]
12. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
13. Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.
Gille J; Spieth K; Kaufmann R
J Dtsch Dermatol Ges; 2005 Jan; 3(1):26-32. PubMed ID: 16353746
[TBL] [Abstract][Full Text] [Related]
14. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.
Schättler H; Ledzewicz U; Amini B
J Math Biol; 2016 Apr; 72(5):1255-80. PubMed ID: 26089097
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of endogenous angiogenesis inhibitors: a mechanism of action of metronomic chemotherapy.
Ng SS; Figg WD
Cancer Biol Ther; 2004 Dec; 3(12):1212-3. PubMed ID: 15662130
[TBL] [Abstract][Full Text] [Related]
16. Five years of clinical experience with metronomic chemotherapy: achievements and perspectives.
Emmenegger U; Kerbel RS
Onkologie; 2007 Dec; 30(12):606-8. PubMed ID: 18063872
[No Abstract] [Full Text] [Related]
17. Metronomic chemotherapy for advanced breast cancer patients.
Cazzaniga ME; Dionisio MR; Riva F
Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
[TBL] [Abstract][Full Text] [Related]
18. Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
Kamat AA; Kim TJ; Landen CN; Lu C; Han LY; Lin YG; Merritt WM; Thaker PH; Gershenson DM; Bischoff FZ; Heymach JV; Jaffe RB; Coleman RL; Sood AK
Cancer Res; 2007 Jan; 67(1):281-8. PubMed ID: 17210709
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.
Bodzioch M; Bajger P; Foryś U
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2281-2299. PubMed ID: 34050795
[TBL] [Abstract][Full Text] [Related]
20. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
